Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1989-10-04
1994-02-08
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424530, 514165, 514264, 514332, 514277, 514396, 514400, 514458, 514420, 514557, 514570, A61K 4904, A61K 3140, A61K 31415, A61K 31435
Patent
active
052846458
ABSTRACT:
Disclosed are fluorocarbon emulsions comprising amino acids and substances related to amino acids, such as substituted amino acids or amphoteric groups of amino acid side chains, for example, the imidazolyl group of histidine. Emulsion formulations comprising imidazole and imidazole based drugs possess anti-inflammatory and antipyretic properties which counteract transient inflammatory responses which occur when these emulsions are administered in vivo. Lipid constituents of histidine-containing emulsions are protected against oxidation caused by free radical formation.
Disclosed also are emulsion formulations buffered with amino acids comprising histidine, imidazole, and related compounds that have a buffering capacity sufficient to maintain the emulsion pH within a specified range under storage conditions and protect these emulsions from the endogenous production of acid. Disclosed also is a method of calculation which assists in the selection of an optimum buffer composition and concentration to preserve physiological compatibility and stability of the emulsions within selected pH limits.
REFERENCES:
patent: 4073879 (1978-02-01), Long
patent: 4278654 (1981-07-01), Rakli et al.
patent: 4285928 (1981-08-01), Wada et al.
patent: 4415556 (1983-11-01), Bretschneider
patent: 4865836 (1989-07-01), Long
patent: 4987154 (1991-01-01), Long
Long, David M., Jr., 0307087, 15 Mar. 1989, Bulletin 89/11.
Neiss, Edward S., WO89/00848, 9 Feb. 1989, abstract.
Zipser, R. et al., Circulation Research 47(2): 231-237 (1980).
Saito, H. et al., Nephron 36: 38-45 (1984).
Okegawa, T. et al., J. of Pharmacology and Experimental Therapeutics 225(1): 213-218 (1983).
Schirmer, W. et al., Current Surgery Mar.-Apr.: 102-105 (1987).
Matheson, R. et al., Photochemistry and Photobiology, 21: 165-171 (1975).
Abe, H. et al., Am. J. Physiol. 249: R449-R454 (1985).
Parkhouse, W. S. et al., J. Appl. Physiol. 58(1): 14-17 (1985).
Kresh, J. Y. et al., J. of Thoracic and Cardiovascular Surgery, 93(2):309-311 (1987).
Riess, J., Artificial Organs 8(1): 44-56 (1984).
J. Riess et al. Int'l Symposium on Blood Substitutes, Montreal, May (1987).
Ferrari, F. et al., Arch. Int. Pharmacodyn. 277: 303-312 (1985).
Ferrari, F. et al., Psychopharmacology 88: 58-62 (1986).
Maguire, E. and Wallis, R., Thrombosis Research 32: 15-27 (1983).
Kazic, T., European J. of Pharmacology 41: 103-111 (1977).
Ogletree, M. L. et al., J. of Pharmacol. and Exper. Therapeutics 234(2): 435-441 (1985).
Golino, P. et al., Circulation 79: 911-919 (1989).
Cao, Y-Z. et al., Biochem. J. 247: 135-140 (1987).
Aiken, J. et al., Jour. of Pharmacology and Experimental Therapeutics 219(2): 299-308 (1981).
Cadnapaphornchai, P. et al., Amer. J. Physiol. 243: F532-F536 (1982).
Ferrari, F. and G. Baggio, Life Sciences 36: 1397-1405 (1985).
Ferrari, F. et al., Psychopharmacology 93: 19-24 (1987).
Fitgerald, G. A. et al., J. Clin. Invest. 71: 1336-1343 (1983).
Lianos, E. A. et al., J. Clin. Invest. 72: 1439-1448 (1983).
Needleman, P. et al., in Proc. Natl. Acad. Sci. 74(4): 1716-1720 (1977).
Needleman, P. et al., Prostaglandins 14(5): 897-907 (1977).
Needleman, P. et al., J. Clin. Invest. 63: 345-349 (1979).
Nilsson, K. et al., Acta Physiol. Scand. 98: 407-411 (1976).
Patterson, G. A. et al., J. Applied Physiol. 58(3): 892-898 (1985).
Purkerson, M. L. et al., Amer. Proc. Natl. Acad. Sci. USA 82: 193-197 (1985).
Redondo, J. M. et al., Immunology Letters 14: 111-116 (1986/1987).
Tai, H.-H. and B. Yuan, Biochem. Biophys. Res. Commun. 80(1): 236-242 (1978).
Alliance Pharmaceutical Corp.
Criares T. J.
Waddell Frederick E.
LandOfFree
Fluorocarbon emulsions containing amino acid based anti-inflamat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluorocarbon emulsions containing amino acid based anti-inflamat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorocarbon emulsions containing amino acid based anti-inflamat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-696243